219 related articles for article (PubMed ID: 36482903)
1. Novel insight of N
Wang K; Kan Q; Ye Y; Qiu J; Huang L; Wu R; Yao C
Front Genet; 2022; 13():1055396. PubMed ID: 36482903
[No Abstract] [Full Text] [Related]
2. m6A Regulator-Mediated Tumour Infiltration and Methylation Modification in Cervical Cancer Microenvironment.
Zhang W; Xiao P; Tang J; Wang R; Wang X; Wang F; Ruan J; Yu S; Tang J; Huang R; Zhao X
Front Immunol; 2022; 13():888650. PubMed ID: 35572541
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Analysis of N6-methyladenosine Modification Patterns Associated With Multiomic Characteristics of Bladder Cancer.
Liu J; Wang J; Wu M; Zhang W; Meng L; Wang J; Lv Z; Xia H; Zhang Y; Wang J
Front Med (Lausanne); 2021; 8():757432. PubMed ID: 35004726
[No Abstract] [Full Text] [Related]
4. m6A-Mediated Tumor Invasion and Methylation Modification in Breast Cancer Microenvironment.
Liu F; Yu X; He G
J Oncol; 2021; 2021():9987376. PubMed ID: 34745261
[TBL] [Abstract][Full Text] [Related]
5. Construction of a risk prediction model using m6A RNA methylation regulators in prostate cancer: comprehensive bioinformatic analysis and histological validation.
Quan Y; Zhang X; Ping H
Cancer Cell Int; 2022 Jan; 22(1):33. PubMed ID: 35045837
[TBL] [Abstract][Full Text] [Related]
6. Integrative Analysis of m6A RNA Methylation Regulators and the Tumor Immune Microenvironment in Non-Small-Cell Lung Cancer.
Zhu J; Jiang Y; Wang T; Wu A; Zhou T; Zhang A; Tang Y; Shen Z; Wang J; Zhou H; Shi J; Chen J
Dis Markers; 2022; 2022():2989200. PubMed ID: 35186164
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatic analyses of the role of m6A RNA methylation regulators in abdominal aortic aneurysm.
Fu C; Feng L; Zhang J; Sun D
Ann Transl Med; 2022 May; 10(10):547. PubMed ID: 35722410
[TBL] [Abstract][Full Text] [Related]
8. Identification of prognostic m6A modification patterns and score system in melanoma patients.
Wang F; Chen P; Ouyang S; Xiong K; Liu Z; Wang Y
Medicine (Baltimore); 2024 Apr; 103(17):e37950. PubMed ID: 38669381
[TBL] [Abstract][Full Text] [Related]
9. N6-methyladenosine methylation modification patterns reveal immune profiling in pancreatic adenocarcinoma.
Xu H; Yin L; Xu Q; Xiang J; Xu R
Cancer Cell Int; 2022 May; 22(1):199. PubMed ID: 35606813
[TBL] [Abstract][Full Text] [Related]
10. Expression Pattern and Clinical Value of Key m6A RNA Modification Regulators in Abdominal Aortic Aneurysm.
Li T; Wang T; Jing J; Sun L
J Inflamm Res; 2021; 14():4245-4258. PubMed ID: 34511965
[TBL] [Abstract][Full Text] [Related]
11. Molecular subtypes based on N6-methyladenosine RNA methylation demonstrate the heterogeneity of immune and biological functions in pediatric septic shock.
Wang H; Huang J; Guo C; Wu J; Zhang L; Ren X; Gan L
Heliyon; 2023 Oct; 9(10):e20714. PubMed ID: 37842565
[TBL] [Abstract][Full Text] [Related]
12. Analysis of N6-Methyladenosine Modification Patterns and Tumor Immune Microenvironment in Pancreatic Adenocarcinoma.
Liu Y; Li G; Yang Y; Lu Z; Wang T; Wang X; Liu J
Front Genet; 2021; 12():752025. PubMed ID: 35046996
[No Abstract] [Full Text] [Related]
13. The m6A methylation landscape stratifies hepatocellular carcinoma into 3 subtypes with distinct metabolic characteristics.
Shen X; Hu B; Xu J; Qin W; Fu Y; Wang S; Dong Q; Qin L
Cancer Biol Med; 2020 Nov; 17(4):937-952. PubMed ID: 33299645
[TBL] [Abstract][Full Text] [Related]
14. Thyroid cancer risk prediction model using m6A RNA methylation regulators: integrated bioinformatics analysis and histological validation.
Zhou W; Lin J; Liu J; Zhang R; Fan A; Xie Q; Hong L; Fan D
Aging (Albany NY); 2023 Feb; 15(3):846-865. PubMed ID: 36791151
[TBL] [Abstract][Full Text] [Related]
15. N6-methyladenosine regulator-mediated methylation modification patterns and immune infiltration characterization in Polycystic Ovary Syndrome (PCOS).
Zhou S; Hua R; Quan S
J Ovarian Res; 2023 Apr; 16(1):73. PubMed ID: 37046273
[TBL] [Abstract][Full Text] [Related]
16. m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma.
Huang X; Qiu Z; Li L; Chen B; Huang P
Aging (Albany NY); 2021 Aug; 13(16):20698-20715. PubMed ID: 34461607
[TBL] [Abstract][Full Text] [Related]
17. Characterization of m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration in Ovarian Cancer.
Luo Y; Sun X; Xiong J
Front Cell Dev Biol; 2021; 9():794801. PubMed ID: 35087835
[No Abstract] [Full Text] [Related]
18. Molecular Characteristics of m6A Regulators and Tumor Microenvironment Infiltration in Soft Tissue Sarcoma: A Gene-Based Study.
Xiao KW; Yang ZQ; Yan X; Liu ZB; Yang M; Guo LY; Cai L
Front Bioeng Biotechnol; 2022; 10():846812. PubMed ID: 35519620
[No Abstract] [Full Text] [Related]
19. Significance of N6-Methyladenosine RNA Methylation Regulators in Immune Infiltrates of Ovarian Cancer.
Gu J; Bi F
Front Genet; 2021; 12():671179. PubMed ID: 34306015
[TBL] [Abstract][Full Text] [Related]
20. The Role of m6A Regulator-Mediated Methylation Modification and Tumor Microenvironment Infiltration in Glioblastoma Multiforme.
Wang L; Cao H; Zhong Y; Ji P; Chen F
Front Cell Dev Biol; 2022; 10():842835. PubMed ID: 35265626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
